Back to Index vs quant Value Fund

A weighted portfolio overlap of 3.03% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹3.03 is allocated to the exact same companies at the same relative proportions. The schemes share 3 common holdings.

The largest overlapping asset in their portfolios is Aurobindo Pharma, which commands a weight of 2.76% in Back to Index and 3.80% in quant Value Fund. Holding both schemes increases your concentration in Aurobindo Pharma rather than expanding your diversification.

If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).